MedTrace Logo

Depo-Medrol on Psoas After LLIF

NCT05929755 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-07-24

No results posted yet for this study

Summary

The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.

Conditions

  • Muscle Weakness
  • Pain, Postoperative
  • Paresthesia
  • Pain, Muscle

Interventions

DRUG

Depo-Medrol

steroid

DRUG

Gel-Flow NT

hemostatic agent

Sponsors & Collaborators

  • Society for Minimally Invasive Spine Surgery

    collaborator OTHER

  • Hardeep Singh

    lead OTHER

Principal Investigators

  • Hardeep Singh, M.D. · UConn Health

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-12
Primary Completion
2025-08-31
Completion
2027-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05929755 on ClinicalTrials.gov